TABLE 2.
Multivariate analysis of clinical features of RSV LTRI during two RSV study seasons
| 2020/2021 | 2014/2017 | P value | |
|---|---|---|---|
| Total case number | 80 | 48 | |
| Clinical manifestations | |||
| Duration of fever (day) | 2.5 ± 0.3 | 4.0 ± 0.4 | 0.004 |
| Hospitalization duration (day) | 5.5 ± 0.2 | 5.6 ± 0.3 | 0.803 |
| Oxygen demand | 29 (36.3%) | 35 (72.9%) | 0.021 |
| Systemic steroid use | 24 (30%) | 6 (12.5%) | 0.026 |
| Bronchodilator use | 53 (66.3%) | 23 (47.9%) | 0.523 |
| Intensive care | 12 (15.2%) | 5 (10.4%) | 0.373 |
| Laboratory findings | |||
| White cell count (× 104/ul) | 9932.4 ± 461.7 | 10551.3 ± 619.5 | 0.430 |
| N/L ratio | 1.7 ± 0.2 | 1.6 ± 0.2 | 0.823 |
| CRP (mg/dl) | 1.0 ± 0.2 | 1.4 ± 0.3 | 0.326 |
Abbreviations: CRP, C‐reactive protein; N/L ratio, neutrophil/lymphocyte count ratio; RSV, respiratory syncytial virus.
Multivariable analysis controlled for age and sex, and data are presented as marginal mean ± standard error. Continuous data were analyzed using a general linear model; categorical data were analyzed using logistic regression.